Kronos Bio (KRON) Investor Presentation - Slideshow
*Prior midostaurin (N = 37) OS HR = 0.70 Our clinical programs • KB-0742 (CDK9 inhibitor) | --- | --- | |------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------| | Strong Financial Position | Corporate Partnerships | | Approx. $247.9 million in cash, cash equivalents and investments (as of Dec. 31, 2022) | • Platform disc ...